Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.95
BATS BZX Real-Time Price
As of 10:17am ET
 -0.015 / -0.22%
Today’s Change
4.60
Today|||52-Week Range
8.63
+16.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues44.4M8.7M69.4M11.7M
 
 
 
 
 
Cost of Goods Sold855.0K------
 
 
Depreciation And Amortization545.0K565.0K2.1M1.1M
 
 
 
 
 
 
Operating ExpensesGross Income43.0M------
 
 
General Expenses42.7M45.4M58.8M66.4M
 
 
 
 
 
Research And Development27.7M28.2M37.6M42.6M
 
 
 
 
 
Total Operating Expenses44.1M46.0M60.9M67.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income296.0K-37.3M8.5M-55.8M
 
 
 
 
 
Extraordinary Credit7.3M0.004.6M--
 
 
 
Extraordinary Charge-4.2M-2.0M0.00-2.6M
 
 
 
 
Interest Expense On Debt0.000.00800.0K5.1M
 
 
 
Other Expenses0.000.00-34.0K-247.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income3.4M-39.3M12.6M-62.7M
 
 
 
 
 
Income Taxes-989.0K-133.0K-1.8M-11.7M
 
 
 
 
 
Minority Interest0.00-7.0K-73.0K0.00
 
 
 
Net Income4.4M-39.1M10.8M-51.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS68.2M69.7M70.0M70.3M
 
 
 
 
 
Shares To Calculate EPS Diluted68.2M69.7M70.2M70.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.06-$0.56$0.15-$0.73
 
 
 
 
 
EPS Diluted$0.06-$0.56$0.15-$0.73